首页> 外文期刊>Journal of Clinical Microbiology >Clinical Utility of Laboratory Detection of Clostridium difficile Strain BI/NAP1/027
【24h】

Clinical Utility of Laboratory Detection of Clostridium difficile Strain BI/NAP1/027

机译:艰难梭菌菌株BI / NAP1 / 027实验室检测的临床实用性

获取原文
           

摘要

Clostridium difficile strain BI/NAP1/027 is associated with increased C. difficile infection (CDI) rates and severity, and the efficacy of some CDI therapies may be strain dependent. Although cultured C. difficile isolates can be reliably subtyped by various methods, the long turnaround times, high cost, and limited availability of strain typing preclude their routine use. Nucleic acid amplification tests identify BI/NAP1/027 rapidly from stool, but the emergence of closely related strains compromises test specificity. Although detection of epidemiologically significant pathogens is generally useful for infection control programs, specific data supporting use of rapid detection of BI/NAP1/027 as an infection control tool are still awaited.
机译:艰难梭菌菌株BI / NAP1 / 027与艰难梭菌感染(CDI)的发生率和严重程度相关,某些CDI疗法的疗效可能与菌株有关。尽管培养的艰难梭菌分离株可以通过各种方法可靠地亚型化,但长的周转时间,高成本和菌株分型的有限可用性阻碍了它们的常规使用。核酸扩增试验可从粪便中快速鉴定出BI / NAP1 / 027,但密切相关的菌株的出现损害了试验的特异性。尽管流行病学上重要病原体的检测通常可用于感染控制程序,但仍在等待支持将BI / NAP1 / 027快速检测用作感染控制工具的具体数据。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号